DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 2 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Recs

0
Player Avatar loop1981 (< 20) Submitted: 2/11/2007 3:36:58 AM : Outperform Start Price: $4.42 DRRX Score: -76.44

have a nice mature pipeline and cheap right now

Report this Post 1 Comment
Member Avatar loop1981 (< 20) Submitted: 2/26/2007 8:35:44 PM
Recs: 0

loaded up on this one lately. Looking for some big news coming soon. ;)

Featured Broker Partners


Advertisement